Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0510-2013Class II

Siemens Healthcare ADVIA Centaur Digitoxin (DGTN) 250 Test 09046419 50 Test 08861968 Intended Use For in...

Siemens Healthcare Diagnostics Inc. / initiated 2012-11-14 / Terminated / root cause: design

Siemens Healthcare Diagnostics, Inc began a recall of Siemens Healthcare ADVIA Centaur Digitoxin (DGTN) 250 Test 09046419 50 Test 08861968 Intended Use For in vitro diagnostic use in the quantitative determination... on . FDA classified it as Class II and gives the reason as "Operating range of the ADVIA Centaur systems is 18C to 30C (64.4F to 86.0F), a change in room temperature may increase or decrease assay results, depending on the specific assay and ADVIA Centaur system used". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-0510-2013
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Siemens Healthcare Diagnostics Inc.
Product
Siemens Healthcare ADVIA Centaur Digitoxin (DGTN) 250 Test 09046419 50 Test 08861968 Intended Use For in vitro diagnostic use in the quantitative determination of digitoxin in serum or plasma using the ADVIA Centaur and ADVIA Centaur XP systems.
Product code
LFM Enzyme Immunoassay, Digitoxin
Reason for recall
Operating range of the ADVIA Centaur systems is 18C to 30C (64.4F to 86.0F), a change in room temperature may increase or decrease assay results, depending on the specific assay and ADVIA Centaur system used.
Root cause tag
design
FDA root cause
Device Design
Action
Siemens Healthcare issued An Urgent Medical Device Correction Notice (for US customers) and an Urgent Field Safety Notice (for customers outside the US) dated November 5, 2012, to all affected customers. These notices inform customers who used the ADVIA Centaur BNP, BR, CA 19-9, Digitoxin, Folate, and Theophylline 2 assays to reduce their instrument operating temperature range to 20 -25 degrees C and for the DHEAS assay to reduce the instrument operating temperature range to 18 -26 degrees C when these assays are being used. These notices also direct customers to review the contents of the correction notice with their Laboratory Director or Medical Director. A confirmation fax-back form was included to ensure that all customers worldwide have been notified and have complied with the mandatory action. Customers with questions were instructed to contact their Siemens Technical Solutions Center or their local technical support representative. For questions regarding this recall call 508-668-5000.
Quantity in commerce
50 test=792 and 250 test=525
Distribution
Worldwide Distribution - USA (nationwide) and Internationally to the following countries: Argentina Australia Austria Azerbaijan Belgium Bosnia Herzeg. Brazil Canada Chile COLOMBIA Croatia Czech Republic Denmark Egypt Estonia Finland France Germany Greece Hong Kong Hungary Iceland India Indonesia Iran Ireland Italy Japan Kazakhstan Latvia Lithuania Malaysia Mexico Netherlands New Caledonia Norway Oman P.R. China Philippines Poland Portugal Qatar Rep. of Yemen Republic Korea Reunion Romania Russian Fed. Saudi Arabia Serbia Slovakia Slovenia South Africa Spain Sweden Switzerland Taiwan Thailand Turkey U.A.E. United Kingdom Uruguay Vietnam
Product codes and lots
All lot codes

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0510-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0506-2013Class IITerminatedVoluntary: Firm initiated
Z-0507-2013Class IITerminatedVoluntary: Firm initiated
Z-0508-2013Class IITerminatedVoluntary: Firm initiated
Z-0509-2013Class IITerminatedVoluntary: Firm initiated
Z-0510-2013Class IITerminatedVoluntary: Firm initiated
Z-0511-2013Class IITerminatedVoluntary: Firm initiated
Z-0512-2013Class IITerminatedVoluntary: Firm initiated